KALV
Price
$13.35
Change
+$0.43 (+3.33%)
Updated
Jun 3 closing price
Capitalization
663.7M
29 days until earnings call
XOMAO
Price
$25.20
Change
-$0.06 (-0.24%)
Updated
Jun 3 closing price
Capitalization
N/A
Interact to see
Advertisement

KALV vs XOMAO

Header iconKALV vs XOMAO Comparison
Open Charts KALV vs XOMAOBanner chart's image
KalVista Pharmaceuticals
Price$13.35
Change+$0.43 (+3.33%)
Volume$914.52K
Capitalization663.7M
XOMA
Price$25.20
Change-$0.06 (-0.24%)
Volume$2.36K
CapitalizationN/A
KALV vs XOMAO Comparison Chart
Loading...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KALV vs. XOMAO commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALV is a StrongBuy and XOMAO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (KALV: $13.35 vs. XOMAO: $25.20)
Brand notoriety: KALV and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALV: 161% vs. XOMAO: 49%
Market capitalization -- KALV: $663.7M vs. XOMAO: $0
KALV [@Biotechnology] is valued at $663.7M. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALV’s FA Score shows that 0 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • KALV’s FA Score: 0 green, 5 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMAO is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALV’s TA Score shows that 5 TA indicator(s) are bullish.

  • KALV’s TA Score: 5 bullish, 5 bearish.

Price Growth

KALV (@Biotechnology) experienced а +18.98% price change this week, while XOMAO (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.74%. For the same industry, the average monthly price growth was +2.75%, and the average quarterly price growth was +0.73%.

Reported Earning Dates

KALV is expected to report earnings on Sep 04, 2025.

Industries' Descriptions

@Biotechnology (+5.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KALV YTD gains are higher at: 57.615 vs. XOMAO (2.359). XOMAO has higher annual earnings (EBITDA): -5.42M vs. KALV (-173.23M). KALV has more cash in the bank: 253M vs. XOMAO (93.3M). KALV has less debt than XOMAO: KALV (5.78M) vs XOMAO (119M). XOMAO has higher revenues than KALV: XOMAO (10.2M) vs KALV (0).
KALVXOMAOKALV / XOMAO
Capitalization664MN/A-
EBITDA-173.23M-5.42M3,194%
Gain YTD57.6152.3592,442%
P/E RatioN/AN/A-
Revenue010.2M-
Total Cash253M93.3M271%
Total Debt5.78M119M5%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KALV
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLFIX28.72N/A
N/A
Principal Large Cap S&P 500 Index Inst
STVYX17.89N/A
N/A
SEI Tax-Managed Mgd Volatility Y (SIMT)
PGKRX26.86N/A
N/A
PGIM Jennison Technology R6
TRSYX14.55N/A
N/A
T. Rowe Price Small-Cap Index
CRLVX10.69N/A
N/A
Catholic Rspnsbl Invstmnts Intl Eq Inv

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
-0.24%
AMLX - XOMAO
68%
Closely correlated
+0.39%
XOMAP - XOMAO
31%
Poorly correlated
-1.04%
ATAI - XOMAO
24%
Poorly correlated
-5.62%
LTRN - XOMAO
23%
Poorly correlated
+0.94%
KALV - XOMAO
23%
Poorly correlated
+3.33%
More